Pembrolizumab
Pembrolizumab is a humanized antibody. It is a highly selective IgG4-kappa humanized monoclonal antibody against PD-1 receptor. It is used in cancer immunotherapy.Reference standards of Pembrolizumab API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Pembrolizumab - API Standards
[catalogue_number] => PA 16 2650000
[category_ids] => ,78,70,82,
[chemical_name] =>
[weight] => 6517.39
[form] => C292H442N78O86S3
[cas] => 1374853-91-4
[pslug] => 1374853-91-4-pembrolizumab-pa162650000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Pembrolizumab - API Standards
Catalogue No.:PA 16 2650000
Molecular Formula : C292H442N78O86S3
Molecular Weight : 6517.39